These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 35671994)
1. Dietary habits and lifestyle related to the effectiveness of low-intensity extracorporeal shock wave therapy for chronic prostatitis/chronic pelvic pain syndrome-like symptoms: Initial results. Bian Z; Jin C; Mo F; Zhang S; Meng J; Zhang M; Zhang L; Chen X; Hao Z; Song Z; Liang C Andrologia; 2022 Oct; 54(9):e14490. PubMed ID: 35671994 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of low-intensity extracorporeal shock wave therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome: A systematic review and meta-analysis. Yuan P; Ma D; Zhang Y; Gao X; Liu Z; Li R; Wang T; Wang S; Liu J; Liu X Neurourol Urodyn; 2019 Aug; 38(6):1457-1466. PubMed ID: 31037757 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Extracorporeal Shock Wave Therapy in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Acquired Premature Ejaculation Patients. Sokmen D; Comez YI Urol Int; 2023; 107(9):872-876. PubMed ID: 37611558 [TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of extracorporeal shock wave therapy (Li-ESWT) protocols in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients. Sokmen D; Comez YI Aging Male; 2023 Dec; 26(1):2253876. PubMed ID: 37671978 [TBL] [Abstract][Full Text] [Related]
7. [Extracorporeal shock wave therapy for chronic prostatitis / chronic pelvic pain syndrome: A meta-analysis]. Liao B; Mou XX; Liu JB; Wu T; Cui S Zhonghua Nan Ke Xue; 2019 Oct; 25(10):914-922. PubMed ID: 32233224 [TBL] [Abstract][Full Text] [Related]
8. Li-ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models. Feng B; Dong Z; Wang Y; Yan G; Yang E; Cheng H; Liang C; Hao Z; Zhang X; Song Z; Jiang Z; Chen M; Yue Z; Wang Z Andrology; 2021 Sep; 9(5):1593-1602. PubMed ID: 33960707 [TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis. Kong X; Hu W; Dong Z; Tian J; Wang Y; Jin C; Liang C; Hao Z; Wang Z Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):483-494. PubMed ID: 35798855 [TBL] [Abstract][Full Text] [Related]
10. The Efficacy and Safety of Extracorporeal Shockwave Therapy versus Acupuncture in the Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Evidence Based on a Network Meta-analysis. Kang Y; Song P; Cao D; Di X; Lu Y; Liu P; Dong Q Am J Mens Health; 2021; 15(6):15579883211057998. PubMed ID: 34911370 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy on Men With Chronic Pelvic Pain Syndrome Refractory to 3-As Therapy. Guu SJ; Geng JH; Chao IT; Lin HT; Lee YC; Juan YS; Liu CC; Wang CJ; Tsai CC Am J Mens Health; 2018 Mar; 12(2):441-452. PubMed ID: 29072124 [TBL] [Abstract][Full Text] [Related]
12. Outcomes and clinical predictors of extracorporeal shock wave therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: a prospective randomized double-blind placebo-controlled clinical trial. Sakr AM; Fawzi AM; Kamel M; Ali MM Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):93-99. PubMed ID: 34635804 [TBL] [Abstract][Full Text] [Related]
13. Comparing the effectiveness of extracorporeal shockwave therapy and myofascial release therapy in chronic pelvic pain syndrome: study protocol for a randomized controlled trial. Huang N; Qin Z; Sun W; Bao K; Zha J; Zhang P; Feng P; Zhao X; Liu M; Shi J; Ma M Trials; 2023 Oct; 24(1):675. PubMed ID: 37853420 [TBL] [Abstract][Full Text] [Related]
14. The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low-intensity extracorporeal shock wave. Kong X; Dong Z; Hu W; Mi J; Xiao J; Wang Y; Chen W; Pei Z; Hao Z; Liang C; Wang Q; Wang Z Prostate; 2024 Dec; 84(16):1525-1536. PubMed ID: 39308020 [TBL] [Abstract][Full Text] [Related]
15. Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis. Song Z; Jin C; Bian Z; Liang C Mol Cell Biochem; 2021 Apr; 476(4):1905-1913. PubMed ID: 33492609 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of extracorporeal shockwave therapy for the treatment of chronic non-bacterial prostatitis: A systematic review and meta-analysis. Birowo P; Rangganata E; Rasyid N; Atmoko W PLoS One; 2020; 15(12):e0244295. PubMed ID: 33370372 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome IIIb: A Prospective-Randomized, Double-Blind, Placebo-Controlled Study. Kim KS; Choi YS; Bae WJ; Cho HJ; Ha US; Hong SH; Lee JY; Ahn ST; Moon DG; Kim SW World J Mens Health; 2022 Jul; 40(3):473-480. PubMed ID: 34448374 [TBL] [Abstract][Full Text] [Related]
19. Low-intensity extracorporeal shock wave therapy for male chronic pelvic pain syndrome: a systematic review and meta-analysis. Li G; Man L Transl Androl Urol; 2021 Mar; 10(3):1202-1211. PubMed ID: 33850755 [TBL] [Abstract][Full Text] [Related]